Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mycotoxins | 1 | 2024 | 12 | 0.880 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2024 | 60 | 0.830 |
Why?
|
| Pancreatic Neoplasms | 1 | 2024 | 206 | 0.720 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 2011 | 200 | 0.550 |
Why?
|
| Lupus Nephritis | 2 | 2012 | 26 | 0.450 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2024 | 101 | 0.440 |
Why?
|
| Kidney | 1 | 2012 | 363 | 0.310 |
Why?
|
| Hepatitis | 1 | 2008 | 11 | 0.290 |
Why?
|
| Jaundice | 1 | 2008 | 7 | 0.290 |
Why?
|
| Spondylarthropathies | 1 | 2008 | 2 | 0.280 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 2006 | 6 | 0.260 |
Why?
|
| Raynaud Disease | 1 | 2006 | 8 | 0.260 |
Why?
|
| Thrombosis | 1 | 2006 | 81 | 0.240 |
Why?
|
| Case-Control Studies | 2 | 2024 | 1265 | 0.200 |
Why?
|
| Puerto Rico | 6 | 2018 | 1376 | 0.190 |
Why?
|
| Alzheimer Disease | 2 | 2021 | 971 | 0.190 |
Why?
|
| Retrospective Studies | 3 | 2024 | 2466 | 0.180 |
Why?
|
| Pilot Projects | 1 | 2024 | 733 | 0.180 |
Why?
|
| Genome-Wide Association Study | 2 | 2021 | 421 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2021 | 8 | 0.170 |
Why?
|
| Genetic Variation | 2 | 2021 | 429 | 0.170 |
Why?
|
| Female | 11 | 2024 | 23980 | 0.170 |
Why?
|
| Hospitalization | 1 | 2024 | 477 | 0.170 |
Why?
|
| Male | 10 | 2024 | 22745 | 0.160 |
Why?
|
| Middle Aged | 5 | 2024 | 11790 | 0.140 |
Why?
|
| Risk Factors | 2 | 2024 | 3933 | 0.140 |
Why?
|
| Apolipoprotein E4 | 1 | 2018 | 62 | 0.140 |
Why?
|
| Adult | 9 | 2024 | 13437 | 0.140 |
Why?
|
| Humans | 12 | 2024 | 42113 | 0.130 |
Why?
|
| Aged | 3 | 2024 | 7958 | 0.120 |
Why?
|
| Drosophila | 1 | 2015 | 150 | 0.110 |
Why?
|
| Genome | 1 | 2015 | 149 | 0.100 |
Why?
|
| Young Adult | 5 | 2024 | 4928 | 0.100 |
Why?
|
| Virus Shedding | 1 | 2013 | 9 | 0.100 |
Why?
|
| Personnel, Hospital | 1 | 2013 | 10 | 0.100 |
Why?
|
| Drosophila Proteins | 1 | 2015 | 183 | 0.100 |
Why?
|
| Evolution, Molecular | 1 | 2015 | 299 | 0.100 |
Why?
|
| Nasal Mucosa | 1 | 2013 | 31 | 0.100 |
Why?
|
| Virus Diseases | 1 | 2013 | 27 | 0.100 |
Why?
|
| Respiratory Tract Infections | 1 | 2013 | 36 | 0.100 |
Why?
|
| Genomics | 1 | 2015 | 289 | 0.100 |
Why?
|
| Biopsy | 1 | 2012 | 176 | 0.090 |
Why?
|
| Cyclophosphamide | 1 | 2010 | 58 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2010 | 53 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2011 | 170 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 94 | 0.080 |
Why?
|
| Disease Progression | 1 | 2011 | 660 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 236 | 0.070 |
Why?
|
| Adolescent | 3 | 2013 | 5949 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2008 | 584 | 0.060 |
Why?
|
| Crohn Disease | 1 | 2024 | 69 | 0.050 |
Why?
|
| Colitis, Ulcerative | 1 | 2024 | 68 | 0.050 |
Why?
|
| Wound Healing | 1 | 2024 | 82 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2024 | 164 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2024 | 131 | 0.050 |
Why?
|
| Prevalence | 1 | 2008 | 1593 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2010 | 3073 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 2 | 2011 | 144 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2021 | 382 | 0.040 |
Why?
|
| Logistic Models | 2 | 2013 | 1001 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2018 | 203 | 0.040 |
Why?
|
| Genetics, Population | 1 | 2018 | 118 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2013 | 1728 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2010 | 1582 | 0.030 |
Why?
|
| Gene Rearrangement | 1 | 2015 | 16 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2015 | 36 | 0.030 |
Why?
|
| Heterochromatin | 1 | 2015 | 19 | 0.030 |
Why?
|
| Codon | 1 | 2015 | 40 | 0.030 |
Why?
|
| Introns | 1 | 2015 | 80 | 0.030 |
Why?
|
| DNA Transposable Elements | 1 | 2015 | 50 | 0.030 |
Why?
|
| Exons | 1 | 2015 | 91 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 2015 | 75 | 0.030 |
Why?
|
| Species Specificity | 1 | 2015 | 279 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2015 | 189 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2013 | 21 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2013 | 53 | 0.020 |
Why?
|
| Infection Control | 1 | 2013 | 17 | 0.020 |
Why?
|
| Tennessee | 1 | 2013 | 88 | 0.020 |
Why?
|
| Computational Biology | 1 | 2015 | 324 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 2790 | 0.020 |
Why?
|
| Influenza, Human | 1 | 2013 | 90 | 0.020 |
Why?
|
| Complement C4 | 1 | 2011 | 4 | 0.020 |
Why?
|
| Proteinuria | 1 | 2011 | 55 | 0.020 |
Why?
|
| Vaccination | 1 | 2013 | 332 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 437 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 512 | 0.020 |
Why?
|
| Antirheumatic Agents | 1 | 2010 | 35 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2010 | 92 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2013 | 1570 | 0.020 |
Why?
|
| Prognosis | 1 | 2011 | 847 | 0.020 |
Why?
|
| Comorbidity | 1 | 2010 | 723 | 0.020 |
Why?
|
| Age Factors | 1 | 2010 | 1135 | 0.020 |
Why?
|
| Animals | 1 | 2015 | 16694 | 0.010 |
Why?
|